STOCK TITAN

PTCT (NASDAQ: PTCT) holder plans sale of 1,739 shares under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of PTCT common stock has filed a Form 144 notice to sell 1,739 common shares. The shares are planned to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 01/06/2026. The filing notes an aggregate market value for this block of $133,811.88 and shows 80,288,305 common shares outstanding.

The 1,739 shares were acquired on 01/05/2026 via restricted stock vesting from the issuer as compensation. Over the past three months, the same seller, identified as Mark Boulding, has reported multiple sales of PTCT common stock, including transactions on 10/06/2025, 10/07/2025, 11/17/2025, and 01/05/2026 with disclosed gross proceeds for each sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What type of SEC filing is this for PTCT?

This is a Form 144 notice, which discloses a planned sale of restricted or control securities of PTCT common stock by an existing holder.

How many PTCT shares are planned to be sold under this Form 144?

The filing states that the holder plans to sell 1,739 shares of PTCT common stock, with an aggregate market value listed as $133,811.88.

When and where are the PTCT shares expected to be sold?

The notice lists an approximate date of sale of 01/06/2026, through Fidelity Brokerage Services LLC, with the securities to be sold on the NASDAQ exchange.

How were the PTCT shares being sold acquired by the holder?

The 1,739 PTCT common shares were acquired on 01/05/2026 through restricted stock vesting from the issuer, described as compensation in the filing.

What prior PTCT stock sales by this holder are disclosed in the last 3 months?

The filing lists prior sales by Mark Boulding of PTCT common stock: 2,266 shares on 10/06/2025, 3,375 shares on 10/07/2025, 2,812 shares on 11/17/2025, and 2,266 shares on 01/05/2026, each with reported gross proceeds.

How many PTCT shares are reported as outstanding in this notice?

The Form 144 indicates that there are 80,288,305 PTCT common shares outstanding at the time of the filing.

Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.07B
78.25M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN